2023-07-16-世界卫生组织-Immunization_Belarus_2023_country_profile_17页_353kb
报告摘要
WHO and UNICEF National Immunization Coverage Estimates Summary
Core Content
WHO and UNICEF jointly estimate national immunization coverage levels to provide a more accurate picture of immunization system performance. These estimates are based on a variety of data sources, including administrative, official, and survey-based data. The estimates are not based on ad hoc adjustments but rather on a systematic review of available data, with consideration of potential biases and expert opinions. When data are missing for a specific country/vaccine/year, interpolation from nearby years is used to estimate the coverage.
Main Vaccines and Coverage Definitions
| Vaccine | Definition |
|---|---|
| BCG | Percentage of births who received one dose of Bacillus Calmette-Guérin vaccine. |
| DTP1 | Percentage of surviving infants who received the 1st dose of diphtheria and tetanus toxoid with pertussis containing vaccine. |
| DTP3 | Percentage of surviving infants who received the 3rd dose of diphtheria and tetanus toxoid with pertussis containing vaccine. |
| Pol3 | Percentage of surviving infants who received the 3rd dose of polio-containing vaccine (either oral or inactivated). |
| IPV1 | Percentage of surviving infants who received at least one dose of inactivated polio vaccine (IPV), reflecting the coverage in countries with different immunization schedules. |
| MCV1 | Percentage of surviving infants who received the 1st dose of measles-containing vaccine (MCV) as recommended. |
| MCV2 | Percentage of children who received the 2nd dose of measles-containing vaccine (MCV) according to the nationally recommended schedule. |
| RCV1 | Percentage of surviving infants who received the 1st dose of rubella-containing vaccine (RCV), based on the first measles-rubella combination vaccine. |
| HepBB | Percentage of births who received a dose of hepatitis B vaccine within 24 hours of delivery, only for countries with a universal birth dose policy. |
| HepB3 | Percentage of surviving infants who received the 3rd dose of hepatitis B-containing vaccine. |
| Hib3 | Percentage of surviving infants who received the 3rd dose of Haemophilus influenzae type b (Hib) containing vaccine. |
| RotaC | Percentage of surviving infants who received the final recommended dose of rotavirus vaccine (either 2nd or 3rd dose depending on the vaccine). |
| PcV3 | Percentage of surviving infants who received the 3rd dose of pneumococcal conjugate vaccine (PcV). |
| YFV | Percentage of surviving infants who received one dose of yellow fever vaccine, in countries where it is part of the national immunization schedule or recommended in at-risk areas. |
Key Information
-
Estimation Methods:
- WHO and UNICEF estimates are country-specific and not borrowed from other countries.
- When no data are available for a specific year, they are interpolated from nearby years.
- For mixed data sources, the most likely estimate is selected with consideration of potential biases.
-
Grade of Confidence (GoC):
- The GoC reflects the empirical support for the estimates and not the quality of data reported by national authorities.
- It is not based on classical measures like confidence intervals.
- GoC is determined by the presence of supporting data sources:
- R+: Supported by reported data.
- D+: Supported by independent denominator data.
- S+: Supported by at least one survey within 2 years.
- R- / D- / S-: Challenges to the estimate.
- In cases where no data sources challenge the estimate, it is considered well-supported.
-
Data Sources:
- Administrative Coverage: Based on reports from health service providers.
- Official Coverage: Estimated by national authorities using a combination of administrative, survey, or other data.
- Survey Coverage: Based on population-based household surveys among children aged 12-23 months or 24-35 months.
-
Data Limitations:
- No nationally representative household survey has been conducted in the last 5 years for most countries.
- MICS 2019 did not include an immunization module.
- Survey data is not available for many years, especially in recent years.
Summary Table
| Year | BCG | DTP1 | DTP3 | Pol3 | IPV1 | MCV1 | MCV2 | RCV1 | HepBB | HepB3 | Hib3 | RotaC | PcV3 | YFV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011 | 99 | 99 | 98 | 99 | NA | 99 | 99 | 99 | NA | 98 | 98 | 98 | 98 | 99 |
| 2012 | 98 | 98 | 98 | 98 | NA | 98 | 97 | 98 | NA | 98 | 98 | 98 | 98 | 98 |
| 2013 | 99 | 99 | 98 | 98 | NA | 99 | 99 | 99 | NA | 98 | 98 | 98 | 98 | 99 |
| 2014 | 98 | 98 | 97 | 97 | NA | 99 | 98 | 97 | NA | 97 | 97 | 97 | 97 | 99 |
| 2015 | 97 | 97 | 97 | 97 | 99 | 99 | 99 | 99 | NA | 99 | 97 | 97 | 97 | 99 |
| 2016 | 98 | 98 | 98 | 98 | 99 | 98 | 98 | 98 | NA | 98 | 98 | 98 | 98 | 98 |
| 2017 | 98 | 98 | 98 | 98 | 98 | 97 | 98 | 98 | NA | 98 | 98 | 98 | 98 | 98 |
| 2018 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | NA | 98 | 98 | 98 | 98 | 98 |
| 2019 | 97 | 98 | 98 | 98 | NA | 98 | 98 | 98 | NA | 98 | 98 | 98 | 98 | 98 |
| 2020 | 97 | 97 | 97 | 97 | 96 | 97 | 98 | 97 | NA | 97 | 97 | 97 | 97 | 98 |
| 2021 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | NA | 98 | 98 | 98 | 98 | 98 |
| 2022 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | NA | 98 | 98 | 98 | 98 | 98 |
Notes on GoC
- GoC=R+ D+: Estimate is supported by reported data and independent denominator.
- GoC=R+ D+ S+: Estimate is supported by reported data, independent denominator, and at least one survey within 2 years.
- GoC=●●: Well-supported estimate.
- GoC=●: Estimate is supported by at least one data source.
- GoC=NA: No survey data available.
Disclaimer
- The data and estimates provided are based on varying quality information.
- The World Health Organization and United Nations Children's Fund take all reasonable precautions to verify the information, but they cannot guarantee its accuracy.
- Users are advised to interpret and use the data with caution, considering the objective for which it is being used.
展开完整摘要
试读结束,高清完整版pdf/doc/ppt,请点下载